[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-338229-en":59,"doc-seo-338229-105":98},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":41,"preview_page_count":19,"preview_urls":80},338229,1374391975076,"Riley","https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics - a Mendelian randomization study and colocalization analysis","Comprehensive proteome-wide Mendelian randomization integrates human plasma proteomics with genetic instruments for breast cancer, aiming to uncover biomarkers and therapeutic targets. Protein quantitative trait locus data were derived from published plasma proteome-wide association studies and combined with breast cancer genetic variants from large consortium datasets. Summary-based MR and colocalization prioritized candidate drug targets, followed by two-sample MR validation and protein-protein interaction network mapping to evaluate links with existing oncology drugs. Ten proteins showed significant association with risk, including candidates supported by tiered evidence and a prognostic biomarker signal for ULK3.","TYPE Original Research PUBLISHED 16 September 2024 DOI 10.3389/fendo.2024.1449668  \nOPEN ACCESS  \nEDITED BY Zili Zhang,  \nNanjing University of Chinese Medicine, China  \nREVIEWED BY  \nZhuang Yanshuang,  \nTaizhou Traditional Chinese Medicine Hospital, China  \nGuochong Jia,  \nVanderbilt University Medical Center, United States  \n*CORRESPONDENCE Huawei Yang  \n [bcyhw163@163.com](bcyhw163@163.com)  \nRECEIVED 15 June 2024  \nACCEPTED 28 August 2024  \nPUBLISHED 16 September 2024  \nCITATION  \nSong J and Yang H (2024) Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics:  \na Mendelian randomization study and colocalization analysis.  \nFront. Endocrinol. 15:1449668 .  \ndoi: 10.3389/fendo.2024.1449668  \nCOPYRIGHT  \n© 2024 Song and Yang. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nIdentifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis  \nJingshuang Song 1,2 and Huawei Yang 1,3*  \n1 Department of Breast Surgery, Guangxi Medical University Cancer Hospital, Nanning, China, 2 Department of Breast and Thyroid Surgery, Afﬁliated Hospital of Guilin Medical University, Guilin, China, 3 Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical University, Nanning, China  \nBackground: The proteome is a crucial reservoir of targets for cancer treatment. While some targeted therapies have been developed, there are still signiﬁcant challenges in early diagnosis and treatment, highlighting the need to identify new biomarkers and therapeutic targets for breast cancer. Therefore, we conducted a comprehensive proteome-wide Mendelian randomization (MR) study to identify novel biomarkers and potential therapeutic targets for breast cancer.  \nMethods: Protein quantitative trait locus (pQTL) data were extracted from two published plasma proteome-wide association studies . Genetic variants associated with breast cancer were obtained from the Breast Cancer Association Consortium, which included 133,384 cases and 113,789 controls, and the Finnish cohort study, comprising 18,786 cases and 182,927 controls. We employed summary-based MR and colocalization methods to identify potential drug targets for breast cancer, which were subsequently validated using a twosample MR approach. Finally, a protein-protein interaction (PPI) network was constructed to detect interactions between the identiﬁed proteins and existing cancer drug targets.  \nResults: Gene-predicted levels of ten proteins were associated with breast cancer risk. Decreased levels of CASP8, DDX58, CPNE1, ULK3, PARK7, and BTN2A1, as well as increased levels of TNFRSF9, TNXB, DNPH1, and TLR1, were linked to an elevated risk of breast cancer. Among these, CASP8 and DDX58 were supported by tier-one evidence, while CPNE1, ULK3, PARK7, and TNFRSF9 received tier-two evidence support. The remaining proteins, TNXB, BTN2A1, DNPH1, and TLR1, were supported by tier-three evidence. CASP8, DDX58, CPNE1, ULK3, PARK7, and TNFRSF9 have already been identiﬁed as targets in drug development and potential therapeutic targets for breast cancer treatment. Additionally, ULK3 showed promise as a prognostic biomarker for breast cancer.  \nFrontiers in Endocrinology 01 [frontiersin.org](frontiersin.org)  \nConclusions: The present study identiﬁed several novel potential drug targetsand biomarkers for breast cancer, providing new insights into its diagnosis and treatmen","cbCainNb74IoUv8Z","https://ap.wps.com/l/cbCainNb74IoUv8Z","pdf",2980817,12,"English","en",105,"# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What is the main objective of this study on breast cancer?\",\"answer\":\"To identify novel biomarkers and potential therapeutic targets for breast cancer by integrating human plasma proteomics with Mendelian randomization and colocalization analyses.\"},{\"question\":\"How were candidate targets and biomarkers selected?\",\"answer\":\"Protein QTL data from plasma proteome-wide association studies were combined with breast cancer genetic variants, then summary-based MR and colocalization prioritized candidates, followed by two-sample MR validation and protein-protein interaction network analysis.\"},{\"question\":\"Which proteins were associated with breast cancer risk in the results?\",\"answer\":\"Gene-predicted levels of ten proteins were associated with risk, with decreased levels of CASP8, DDX58, CPNE1, ULK3, PARK7, and BTN2A1 and increased levels of TNFRSF9, TNXB, DNPH1, and TLR1.\"}]","Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics - a Mendelian randomization study and colocalization analysis | PDF",1790022651,[81,85,89,94],{"page_no":8,"url":82,"width":83,"height":84},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb89020f3d5a5a71bb1952242b11f1c3.webp",983,1389,{"page_no":14,"url":86,"width":87,"height":88},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/708bed0262e7aa16658e1dac845cf08e.webp",982,1388,{"page_no":90,"url":91,"width":92,"height":93},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/958581de61eb4296c1a3d66035218f42.webp",981,1387,{"page_no":19,"url":95,"width":96,"height":97},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77d3f390ca12df7433dd1e8e4e10cfc6.webp",980,1385,{"code":4,"msg":99,"data":100},"ok",{"site_id":75,"language":74,"slug":101,"title":65,"keywords":102,"description":66,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"identifying-new-biomarkers-and-potential-therapeutic-targets-for-breast-cancer-through-the-integration-of-human-plasma-proteomics-a-mendelian-randomization-study-and-colocalization-analysis","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":9,"@type":111,"position":14},"https://docshare.wps.com/document/",{"item":115,"name":40,"@type":111,"position":90},"https://docshare.wps.com/document/research-report/",{"item":117,"name":65,"@type":111,"position":19},"https://docshare.wps.com/document/identifying-new-biomarkers-and-potential-therapeutic-targets-for-breast-cancer-through-the-integration-of-human-plasma-proteomics-a-mendelian-randomization-study-and-colocalization-analysis/338229/",{"url":117,"name":65,"@type":119,"image":120,"author":125,"headline":65,"publisher":127,"fileFormat":130,"inLanguage":74,"description":66,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/identifying-new-biomarkers-and-potential-therapeutic-targets-for-breast-cancer-through-the-integration-of-human-plasma-proteomics-a-mendelian-randomization-study-and-colocalization-analysis/338229.png","ImageObject",300,407,{"name":63,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":135,"interactionType":136,"userInteractionCount":52},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"What is the main objective of this study on breast cancer?","Question",{"text":145,"@type":146},"To identify novel biomarkers and potential therapeutic targets for breast cancer by integrating human plasma proteomics with Mendelian randomization and colocalization analyses.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"How were candidate targets and biomarkers selected?",{"text":150,"@type":146},"Protein QTL data from plasma proteome-wide association studies were combined with breast cancer genetic variants, then summary-based MR and colocalization prioritized candidates, followed by two-sample MR validation and protein-protein interaction network analysis.",{"name":152,"@type":143,"acceptedAnswer":153},"Which proteins were associated with breast cancer risk in the results?",{"text":154,"@type":146},"Gene-predicted levels of ten proteins were associated with risk, with decreased levels of CASP8, DDX58, CPNE1, ULK3, PARK7, and BTN2A1 and increased levels of TNFRSF9, TNXB, DNPH1, and TLR1.","https://schema.org",{"og:url":117,"og:type":157,"og:title":65,"og:site_name":128,"og:description":66},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":61,"site_id":75},1790618031]